Product Information

POTASSIUM CL ER 20 MEQ TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1482 per EA under NDC 68462047201. Its NADAC has been published 501 times since Apr 19, 2017.

FDA first approved this application on Jul 26, 2016.

POTASSIUM CL ER 20 MEQ TABLET

potassium chloride
$0.1482per EA

Strength

1500 mg/1

NDC

68462047201

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

POTASSIUM CHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA203562

FDA Approved

7/26/2016

On Market Since

7/26/2016

Pharmacological Classes

Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Osmotic Activity
Osmotic Laxative
Potassium Compounds
Potassium Salt

Price Statistics

The NADAC for POTASSIUM CL ER 20 MEQ TABLET has been published 501 times since Apr 19, 2017, and over the history we have for it it has declined 33.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1482 per EA
All-time high$0.2862 (Jun 10, 2020)
All-time low$0.1196 (Jul 17, 2024)
52-week high$0.1482
52-week low$0.1333
Median price$0.1910
Average price$0.1954
Largest weekly change+28.9% (Nov 20, 2019)
Weeks tracked501
Tracking sinceApr 19, 2017

Price History

1W

+3.1%

1M

+5.3%

3M

+9.7%

6M

+8.4%

1Y

+3.7%

3Y

-0.4%

5Y

-34.6%

All

-33.9%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of POTASSIUM CL ER 20 MEQ TABLET?

The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 20 MEQ TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1482 per EA (NDC 68462047201), effective Nov 18, 2026.

How has the price of POTASSIUM CL ER 20 MEQ TABLET changed over time?

Over the history we have for it, the NADAC for POTASSIUM CL ER 20 MEQ TABLET has declined 33.9%. It has been tracked across 501 weekly CMS publications since Apr 19, 2017.

What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 20 MEQ TABLET?

Since Apr 19, 2017, the NADAC for POTASSIUM CL ER 20 MEQ TABLET has ranged from a low of $0.1196 (Jul 17, 2024) to a high of $0.2862 (Jun 10, 2020), with a median of $0.1910 per EA.

Are there cheaper alternatives to POTASSIUM CL ER 20 MEQ TABLET?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, KLOR-CON M20 TABLET, is $0.1355 per EA — about 9% below POTASSIUM CL ER 20 MEQ TABLET.

Who manufactures POTASSIUM CL ER 20 MEQ TABLET?

POTASSIUM CL ER 20 MEQ TABLET (NDC 68462047201) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.